XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 232.58%109.16M | 156.52%77.22M | -19.69%12.76M | -34.96%136.09M | -17.56%57.29M | -51.45%32.82M | -28.50%30.1M | -47.17%15.88M | 31.45%209.26M | 75.29%69.49M |
Net income from continuing operations | -54.98%9.67M | -2.87%14.06M | 76.49%-594K | -51.98%34.57M | -91.24%1.13M | -14.03%21.49M | -54.48%14.48M | -209.02%-2.53M | 21.12%71.98M | -0.55%12.86M |
Operating gains losses | -27.39%1.71M | -285.17%-5.63M | 647.62%2.67M | 3.96%6.27M | -78.25%521K | 59.39%2.35M | 122.04%3.04M | -54.92%357K | 5,044.26%6.03M | 424.09%2.4M |
Depreciation and amortization | -1.72%33.13M | 2.25%33.58M | 11.68%31.72M | 25.40%127.6M | 22.27%32.65M | 29.36%33.71M | 34.84%32.84M | 15.27%28.4M | 4.69%101.75M | 4.11%26.7M |
Deferred tax | -77.51%2.27M | 206.72%4.15M | 1.52%-10.08M | -120.99%-4.68M | -141.48%-652K | -44.14%10.09M | -174.03%-3.89M | -296.97%-10.23M | 359.98%22.3M | 67.59%1.57M |
Other non cash items | -2.15%3.92M | 94.56%6.98M | -338.09%-5.6M | 311.21%13.57M | 328.30%3.63M | 231.07%4.01M | 196.61%3.59M | 6,811.76%2.35M | -57.23%3.3M | -87.21%848K |
Change In working capital | 253.17%57.45M | 194.30%22.43M | 167.57%1.75M | -744.86%-46.73M | -19.65%17.15M | -267.54%-37.51M | -36.59%-23.78M | -449.53%-2.59M | 72.48%-5.53M | 1,080.43%21.34M |
-Change in receivables | 184.84%37.6M | 140.34%2.82M | -117.35%-24.3M | 64.29%-17.94M | 362.23%44.55M | -56.17%-44.31M | 62.42%-6.99M | 13.22%-11.18M | -213.87%-50.23M | 161.26%9.64M |
-Change in inventory | 259.68%14.66M | 148.18%2.58M | 106.61%188K | 70.61%-2.01M | 99.13%15.37M | -142.93%-9.18M | 63.34%-5.36M | 86.65%-2.85M | 68.60%-6.85M | 289.08%7.72M |
-Change in payables and accrued expense | -316.17%-32.61M | -40.63%5.13M | 259.38%21.35M | -119.49%-6.17M | -512.79%-35.84M | 269.25%15.09M | -67.06%8.64M | -70.56%5.94M | 88.22%31.65M | 29.95%-5.85M |
-Change in other current assets | 146.19%8.07M | 105.16%748K | 43.72%5.1M | -2,090.92%-29.39M | -110.82%-957K | -16.63%-17.46M | -36.78%-14.51M | -80.54%3.55M | 127.23%1.48M | 91.12%8.84M |
-Change in other current liabilities | 62.90%29.91M | 302.46%11.21M | -127.64%-521K | -52.49%8.8M | -695.97%-5.91M | -11.47%18.36M | -2,854.23%-5.54M | 155.23%1.89M | 186.85%18.52M | -48.87%992K |
-Change in other working capital | ---163K | -209.52%-65K | -182.09%-55K | 75.79%-23K | -6,800.00%-69K | --0 | ---21K | 297.06%67K | 26.92%-95K | 50.00%-1K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 232.58%109.16M | 156.52%77.22M | -19.69%12.76M | -34.96%136.09M | -17.56%57.29M | -51.45%32.82M | -28.50%30.1M | -47.17%15.88M | 31.45%209.26M | 75.29%69.49M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -0.23%-28.29M | 70.13%-24.47M | 81.62%-28.18M | -69.14%-296.82M | 69.85%-33.38M | 33.11%-28.22M | -6,603.02%-81.94M | -542.39%-153.29M | -2.16%-175.49M | -66.23%-110.7M |
Net PPE purchase and sale | -88.78%-28.21M | -52.81%28.97M | -114.69%-27.19M | 5.16%199.08M | -126.62%-32.43M | -114.18%-14.94M | 353.97%61.39M | 1,447.43%185.06M | 222.78%189.31M | 73.82%121.83M |
Net intangibles purchase and sale | --0 | ---- | ---- | 74.43%-45K | --0 | 80.39%-10K | ---- | ---- | 28.46%-176K | --0 |
Net business purchase and sale | 99.31%-91K | 62.69%-53.46M | 99.70%-1M | -17.03%-495.87M | 99.58%-967K | 92.60%-13.27M | -133,819.63%-143.29M | -2,780.49%-338.34M | -108.66%-423.73M | -112.27%-232.52M |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 317.39%58.93M | --0 |
Net other investing changes | --14K | --14K | --14K | -89.66%18K | ---- | ---- | ---- | ---- | --174K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -0.23%-28.29M | 70.13%-24.47M | 81.62%-28.18M | -69.14%-296.82M | 69.85%-33.38M | 33.11%-28.22M | -6,603.02%-81.94M | -542.39%-153.29M | -2.16%-175.49M | -66.23%-110.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 33.38%-12.91M | -147.73%-7.4M | -121.97%-20.27M | 708.69%85.36M | -105.03%-3.04M | -302.96%-19.38M | 141.32%15.51M | 522.33%92.26M | 140.01%10.56M | 541.90%60.39M |
Net issuance payments of debt | -192.49%-7.99M | -105.81%-2.42M | -66.04%33.82M | 107.63%152.39M | -79.94%13.91M | -120.29%-2.73M | 1,007.00%41.61M | 2,170.99%99.59M | 729.93%73.39M | 369.87%69.33M |
Net common stock issuance | --0 | 99.40%-68K | -1,281.86%-31.92M | 15.85%-33.69M | ---8.5M | -290,800.00%-11.64M | 58.25%-11.25M | 82.34%-2.31M | ---40.04M | --0 |
Cash dividends paid | 1.78%-4.92M | 2.44%-4.92M | 0.34%-5.01M | -20.30%-20.02M | 2.08%-4.95M | -30.04%-5.01M | -30.97%-5.04M | -29.16%-5.03M | -182.47%-16.64M | -248.34%-5.05M |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---9.81M | --0 | --0 | ---- | ---- | --0 | --0 |
Net other financing activities | --0 | --0 | ---17.16M | 43.04%-3.51M | ---- | ---- | ---- | ---- | 30.40%-6.15M | 0.23%-3.89M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 33.38%-12.91M | -147.73%-7.4M | -121.97%-20.27M | 708.69%85.36M | -105.03%-3.04M | -302.96%-19.38M | 141.32%15.51M | 522.33%92.26M | 140.01%10.56M | 541.90%60.39M |
Net cash flow | ||||||||||
Beginning cash position | 6.70%251.04M | -24.26%205.71M | -23.79%241.42M | 16.23%316.77M | -25.92%220.44M | -10.40%235.28M | 5.73%271.6M | 16.23%316.77M | -12.92%272.54M | 2.57%297.57M |
Current changes in cash | 559.94%67.96M | 224.83%45.34M | 20.95%-35.69M | -270.05%-75.37M | 8.79%20.88M | -142.27%-14.78M | -723.70%-36.32M | -188.57%-45.15M | 213.74%44.32M | 209.41%19.19M |
Effect of exchange rate changes | 117.74%11K | ---19K | 9.52%-19K | 123.71%23K | 783.33%106K | -616.67%-62K | --0 | -31.25%-21K | 93.37%-97K | 150.00%12K |
End cash Position | 44.72%319.01M | 6.70%251.04M | -24.26%205.71M | -23.79%241.42M | -23.79%241.42M | -25.92%220.44M | -10.40%235.28M | 5.73%271.6M | 16.23%316.77M | 16.23%316.77M |
Free cash flow | 1,002.50%79.89M | 1,598.97%57.94M | -119.73%-16.47M | -77.48%24.89M | -50.40%21.73M | -81.80%7.25M | -80.49%3.41M | -179.80%-7.5M | 264.27%110.49M | 131.63%43.8M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |